Ein Unternehmen der RHÖN-KLINIKUM AG

Publikationen 2015


Pfestroff A.

Der Nuklearmediziner 2015;Georg Thieme Verlag KG;DOI 10.1055/s-0034-139858738:56-61

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S
Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460.

Pfestroff A, Luster M.
[How are thyroid nodules diagnosed?].
Dtsch Med Wochenschr. 2015 Apr;140(8):565-72. doi: 10.1055/s-0041-101539. Epub 2015 Apr 1. German.

Willowson KP, Luster M, Tapner M; QUEST Investigator Team, Bailey DL.
A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres : The QUEST Phantom Study.
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1202-22. doi: 10.1007/s00259-015-3059-9. Epub 2015 May 13.

Treglia G, Trimboli P, Verburg FA, Luster M, Giovanella L.
Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule. 

EurJ Clin Invest. 2015 Jul;45(7):739-44. doi: 10.1111/eci.12456. Epub 2015 Jun 1.

Verburg FA, Mäder U, Luster M, Hänscheid H, Reiners C.
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer. 

Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1390-8. doi: 10.1007/s00259-015-3076-8. Epub 2015 Jun 13.

Kletting P, Schimmel S, Hänscheid H, Luster M, Fernández M, Nosske D, Lassmann M, Glatting G.
The NUKDOS software for treatment planning in molecular radiotherapy.
Z Med Phys. 2015 Sep;25(3):264-74. doi:

Kletting P, Kull T, Maaß C, Malik N, Luster M, Beer A, Glatting G. 
Optimized peptide amount and activity for Y-90-labeled DOTATATE therapy.
J Nucl Med. 2015 Dec 17. pii: jnumed.115.164699. [Epub ahead of print] 

Mursina L, Groß V, Librizzi D, Luster M, Sohrabi A, Seifert O,
Hildebrandt O, Heverhagen JT, Koehler U, Sohrabi K.

[Pilot Project: Improved Lung Deposition via a New Nasal Inhalation Procedure]. 

Pneumologie. 2015 Aug;69(8):469-76. doi:10.1055/s-0034-1392444. Epub 2015 Aug 10. German.

Pfestroff A, Luster M, Jilg CA, Olbert PJ, Ohlmann CH, Lassmann M, Maecke HR, Ezziddin S, Bodei L; Radionuclide Therapy Committee of the European Association of Nuclear Medicine.
Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.

Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1971-5. doi: 10.1007/s00259-015-3186-3.
No abstract available.


Maffioli L, Florimonte L, Costa DC, Correia Castanheira J, Grana C, Luster M, Bodei L, Chinol M.
New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer.
Q J Nucl Med Mol Imaging. 2015 Dec;59(4):420-38. Epub 2015 Jul 29.

Luster M.
[Thyroid into the focus of attention].

Nuklearmedizin. 2015;54(3):75-6. German. No abstract available

Pfestroff A., Dietlein M., Luster M.
Nuklearmedizinische Diagnostik, Therapie und Nachsorge des Schilddrüsenkarzinoms

Onkologie 2015; Springer-Verlag .21:597-610.doi:10.1007/s00761-014-2859-z.